Luzi L, Battezzati A, Perseghin G, Bianchi E, Vergani S, Secchi A, La Rocca E, Staudacher C, Spotti D, Ferrari G
Department of Internal Medicine, Istituto Scientifico San Raffaele, University of Milan, Italy.
Diabetes. 1992 Dec;41(12):1632-9. doi: 10.2337/diab.41.12.1632.
In this study, pancreas transplantation is used as a clinical model of pancreas denervation in humans. To assess the role of innervation on the feedback autoinhibition of insulin secretion, we studied four groups of subjects--group 1: 16 patients with combined pancreas and kidney transplantation (plasma glucose = 5.1 mM, HbA1c = 6.4%, creatinine = 86 mM); group 2: 8 patients with chronic uveitis on the same immunosuppressive therapy as transplanted patients (12 mg/day prednisone, 5 mg.kg-1.day-1 CsA); group 3: 4 uremic, nondiabetic patients in chronic hemodialysis; group 4: 7 normal, nondiabetic control subjects. The following means were used to study the groups: 1) a two-step hyperinsulinemic euglycemic clamp (insulin infusion rate = 1 mU and 5 mU.kg-1.min-1); and 2) a 0.3 mU.kg-1.min-1 hypoglycemic clamp (steady-state plasma glucose = 3.1 mM). Basal plasma-free IRI (84 +/- 6, 42 +/- 12, 72 +/- 12, and 30 +/- 6 pM in groups 1, 2, 3, and 4, respectively), basal C-peptide (0.79 +/- 0.05, 0.66 +/- 0.05, 3.04 +/- 0.20, and 0.59 +/- 0.06 nM in groups 1, 2, 3, and 4, respectively), and glucagon (105 +/- 13, 69 +/- 4, 171 +/- 10, and 71 +/- 5 pg/ml in groups 1, 2, 3, and 4, respectively) were increased in groups 1 and 3 with respect to groups 2 and 4 (P < 0.01). During euglycemic hyperinsulinemia, plasma C-peptide decreased by 45, 20, and 44% in groups 2, 3, and 4, respectively, but showed no significant change from the basal in patients with transplanted pancreases.(ABSTRACT TRUNCATED AT 250 WORDS)
在本研究中,胰腺移植被用作人类胰腺去神经支配的临床模型。为评估神经支配对胰岛素分泌反馈性自身抑制的作用,我们研究了四组受试者:第一组:16例接受胰腺和肾脏联合移植的患者(血浆葡萄糖 = 5.1 mM,糖化血红蛋白 = 6.4%,肌酐 = 86 mM);第二组:8例患有慢性葡萄膜炎且接受与移植患者相同免疫抑制治疗的患者(泼尼松12 mg/天,环孢素5 mg·kg-1·天-1);第三组:4例慢性血液透析的尿毒症非糖尿病患者;第四组:7名正常非糖尿病对照受试者。采用以下方法对各组进行研究:1)两步高胰岛素正常血糖钳夹试验(胰岛素输注速率 = 1 mU和5 mU·kg-1·分钟-1);2)0.3 mU·kg-1·分钟-1的低血糖钳夹试验(稳态血浆葡萄糖 = 3.1 mM)。与第二组和第四组相比,第一组和第三组的基础血浆游离胰岛素原(分别为84±6、42±12、72±12和30±6 pM)、基础C肽(分别为0.79±0.05、0.66±0.05、3.04±0.20和0.59±0.06 nM)以及胰高血糖素(分别为105±13、69±4、171±10和71±5 pg/ml)均升高(P < 0.01)。在正常血糖高胰岛素血症期间,第二组、第三组和第四组的血浆C肽分别下降了45%、20%和44%,但胰腺移植患者的血浆C肽与基础值相比无显著变化。(摘要截短至250字)